Compare TKNO & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKNO | ASPI |
|---|---|---|
| Founded | 1996 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.7M | 507.5M |
| IPO Year | 2021 | 2022 |
| Metric | TKNO | ASPI |
|---|---|---|
| Price | $7.33 | $1.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $9.67 | ★ $13.00 |
| AVG Volume (30 Days) | 651.2K | ★ 4.2M |
| Earning Date | 11-04-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.86 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $40,520,000.00 | $23,849,000.00 |
| Revenue This Year | $13.54 | N/A |
| Revenue Next Year | $14.51 | $189.67 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 7.35 | ★ 475.48 |
| 52 Week Low | $1.91 | $1.80 |
| 52 Week High | $9.48 | $9.38 |
| Indicator | TKNO | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 48.37 | 29.73 |
| Support Level | $4.89 | N/A |
| Resistance Level | $7.66 | $3.06 |
| Average True Range (ATR) | 0.64 | 0.17 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 74.07 | 3.37 |
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.